Applied Therapeutics, Inc. (APLT)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-02-04

Key Insights

  • Applied Therapeutics, Inc. (APLT) has been acquired by Cycle Group Holdings Limited through a tender offer and merger, resulting in the cancellation of APLT's outstanding shares and stock options.
  • The Merger Consideration includes $0.088 per share in cash plus one non-tradeable contingent value right, providing APLT shareholders with a mix of immediate cash and potential future upside.
  • The acquisition eliminates APLT's public company status, ending its reporting obligations under SEC regulations such as filing Form 4 insider transaction reports.

Filings on this page are at least 90 days old. In the app, any new Applied Therapeutics, Inc. filing is analysed the moment you open it.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.